Rayyan, Covidence and Elicit overlap, but the right choice depends on what your review team must do and preserve. Start with the protocol, division of work and required audit trail. A platform that produces an attractive summary is not necessarily the platform in which you can defend every inclusion decision or extracted value.
This comparison is published by iatroX and includes its clinical-learning role alongside the specialist review tools. Product descriptions were checked on 19 September 2026. This is a comparison of documented functions and a proposed selection exercise, not a hands-on performance test or a ranking of review accuracy.
Map the work before buying the software
A first clinical review often begins with a question that is too broad for its resources. Before comparing products, agree the population, intervention or exposure, relevant outcomes and eligible study designs. Then identify who will search, screen, resolve disagreements, extract data and assess risk of bias.
The handovers deserve particular attention. Can the second reviewer see the same record? Can the team explain why an article was excluded at full text? Can an extracted result be traced to the correct population and time point? Will another researcher understand the decisions after the original team has moved on?
Write those requirements as tasks, not adjectives. "Transparent" becomes "retain the exclusion reason and reviewer decision". "AI-assisted" becomes "suggest an extraction that a reviewer can verify against a passage". That translation makes a product demonstration much easier to judge.
What the public descriptions establish
As published when checked, Rayyan describes import, deduplication, title and abstract screening, full-text review, extraction, risk-of-bias work and reporting. It also advertises AI-assisted functions. It would therefore be outdated to describe it simply as a basic screening tool without acknowledging its broader current proposition.
Covidence describes a structured review workflow with citation import, screening decisions, full-text exclusion reasons, extraction templates, risk-of-bias work and export. Its documentation explicitly addresses collaboration and records of reviewer votes. Confirm which configuration fits the methodological requirements of the planned review.
Elicit describes AI-supported research, evidence discovery and synthesis workflows. That makes it relevant when the team needs help exploring a question or structuring information from papers. The purchase decision should still inspect the precise controls, source traceability and outputs available for the intended review, rather than assume that a generated report fulfils a systematic-review protocol.
These are provider descriptions, not evidence that one system finds every relevant study or makes error-free judgements. Prices, institutional access and particular feature allowances should be checked for the actual account before purchase.
Use a deliberately awkward selection exercise
Prepare a small, permitted set of records before a demonstration. Include a duplicate with slightly different metadata, a conference abstract and its later paper, an obviously irrelevant record, a borderline population and a paper with several outcome time points. This is a proposed test pack, not a report of testing already performed.
Ask the team to complete the same work in each shortlisted product. Import the records, inspect deduplication, screen independently where required, resolve one disagreement and extract one result. Then export the records and explain a decision without relying on the original reviewer being present.
The purpose is not to calculate an accuracy league table from a tiny sample. It is to discover whether the workflow supports the decisions your review will actually require. A failed export or inaccessible annotation can matter more than a polished introductory dashboard.
Match the buying decision to the bottleneck
| Your team's immediate need | What to examine in the demonstration |
|---|---|
| Coordinated screening | Independent decisions, conflict resolution and retained reasons |
| Consistent extraction | Reusable fields, source locations and handling of several results per study |
| Topic exploration | Search scope, relevance of retrieved papers and limits of coverage |
| Defensible reporting | Exported decisions, study identifiers and a reproducible account of methods |
| A sustainable project | Institutional access, collaboration limits and access after the course ends |
This matrix is an editorial selection framework. It is not an assertion that only one named provider supports each task. The products overlap, and the team's methodological choices remain separate from whichever buttons the interface offers.
An existing institutional subscription may be a sensible starting point. Before buying another platform, establish whether the current tool already handles the difficult handover. Conversely, access being free to the researcher does not make an unsuitable workflow acceptable.
Keep AI suggestions visibly provisional
For screening, decide how suggestions will be used before viewing them. Otherwise, the team may begin with independent review and gradually drift into confirming the software's preferred answer. For extraction, check the population, unit, denominator and time point, not just whether the quoted number appears somewhere in the paper.
An original example illustrates the problem. A paper reports an outcome for all participants and separately for those who completed follow-up. An extracted table contains a correct number but labels it as the whole cohort. The error is not invented arithmetic; it is an incorrect relationship between the number and its denominator.
Record how such disagreements are resolved. The final review should describe the role of automation accurately, including human checks and deviations from the planned method. Software convenience should not rewrite the protocol invisibly.
A verdict by research situation
For a team whose main problem is coordinated screening, start by testing that workflow in Rayyan and Covidence. For a team exploring a clinical question or assessing AI-supported extraction and synthesis, include Elicit, while inspecting its outputs against the review's requirements. For an institutionally supported project, test the existing service before assuming another subscription is necessary.
The September 2026 iatroX brief describes clinical reference and question-specific tutoring, not systematic-review management. Those functions can help a clinician understand an unfamiliar outcome or statistical concept. They do not replace the search record, inclusion decisions, extraction database or risk-of-bias assessment.
Frequently asked questions
Is Elicit a substitute for a systematic-review protocol?
No. Define the method first and then establish which documented functions can support it, including the checks needed on AI-assisted work.
Should I choose the product with the fastest screening demonstration?
Not on speed alone. Check whether the team can retain, explain and export defensible decisions, particularly for difficult records.
Can iatroX manage the screening and extraction database?
That capability is not established by the current product brief; use suitable review-management software and treat iatroX as a complementary learning resource.